Velocity Clinical Research - Union - PPDS

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Bronchiectasis1 trial
• COPD1 trial
• Cystic fibrosis1 trial

Phase

• Phase 22 trials

Status

• Completed1 trial
• Recruiting1 trial

Lead sponsor

• Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA2 trials

Running trials

• Recruiting

  A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis

  NCT06559150· Phase 2· Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA· Source

  Contact: Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway Toll Free Number

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Bronchiectasis1 recruiting
• Cystic fibrosis1 recruiting

Closed trials

• Completed

  Clinical Study of Ensifentrine-Glycopyrrolate (MK-5884A/RPL554) Fixed-dose Combination Dose Ranging in Participants With COPD (MK-5884A-029/RPL554-CO-212)

  NCT07016412· Phase 2· Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA· Source